07/28/2020 12:00 AM EDT
Source: U.S. Government Accountability Office (GAO). Published: 7/28/2020. This two-page document explains how contact tracing can help reduce transmission rates for infectious diseases like COVID-19 by identifying and notifying people who may have been exposed. Contact tracing apps, notably those using proximity tracing, could expedite such efforts. However, there are challenges, including accuracy, adoption rates, and privacy concerns about these apps. (PDF)
07/28/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Center for Preparedness and Response (CDC CPR). Published: 7/28/2020. During this one-hour Clinician Outreach and Communication Activity (COCA) Call, presenters focus on current information about the impact and increased risk for COVID-19 complications in people with diabetes; the importance of diabetes prevention, management, and support; and the many resources and programs available to help patients continue to manage their diabetes and prevent type 2 diabetes during the pandemic. (Video or Multimedia)
07/28/2020 12:00 AM EDT
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 7/28/2020. Speakers on this webinar from TRACIE (Technical Resources, Assistance Center, and Information Exchange) discussed operations, management, and lessons learned of using telemedicine in alternate care sites, which can serve various patient types (e.g., COVID-19 or non-COVID-19) and purposes (e.g., non-acute, hybrid, or acute care). (Video or Multimedia)
07/28/2020 12:00 AM EDT
Source: U.S. Department of Health and Human Services (HHS). Published: 7/28/2020. This 24-page issue brief from the Assistant Secretary for Planning and Evaluation examines changes in Medicare fee-for-service primary care visits and use of telehealth at the start of the COVID-19 public health emergency (PHE). It seeks to address the issue of how and whether the Medicare telehealth flexibilities introduced to address the COVID-19 pandemic may have helped maintain access to primary health care during the PHE. (PDF)
07/27/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/27/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the SNL-NM 2019 nCoV Real-Time RT-PCR Diagnostic assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
07/27/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/27/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Lilly SARS-CoV-2 Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
07/27/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 7/27/2020. While current data suggest that pregnant women, newborns, and children are not at highest risk for COVID-19 deaths, disruption of routine essential services poses a threat to their survival and health. This web page provides guidance for essential maternal, newborn, and child health (MNCH) services to provide during COVID-19. (Text)
07/24/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/24/2020. This four-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Airway Dome. This device is authorized for use by healthcare providers (HCP) as an extra layer of barrier protection in addition to personal protective equipment (PPE) to prevent HCP exposure to pathogenic biological airborne particulates by providing isolation of hospitalized patients with suspected or confirmed diagnosis of COVID-19, at the time of definitive airway management, or when performing airway-related medical procedures, or during certain transport of such patients during the COVID-19 pandemic. (PDF)
07/24/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/24/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of decontaminated, compatible N95 respirators. These compatible N95 respirators have been decontaminated using the Michigan State University Animal Care Program’s (MSU) System for Decontamination and Reuse of Compatible N95 Respirators with Vaporized Hydrogen Peroxide. (PDF)
07/01/2020 12:00 AM EDT
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 7/2020. This seven-page document details TRACIE (Technical Resources, Assistance Center, and Information Exchange)'s interviews with staff from the Urgent Care Association to learn more about their experiences with COVID-19, lessons learned, and plans to work with their local medical communities in the near future. (PDF)
07/01/2020 12:00 AM EDT
Source: United Nations Office for Disaster Risk Reduction (UNDRR). Published: 7/2020. This 88-page report provides a common set of hazard definitions for monitoring and reviewing implementation which calls for “a data revolution, rigorous accountability mechanisms, and renewed global partnerships.” It takes stock of how our understanding of hazards is shifting as we move from managing disasters as events to managing risks, as called for in the Sendai Framework by addressing the systemic drivers of risk in relation to climate change, health, sustainable development, and resilience building. (PDF)
07/01/2020 12:00 AM EDT
Source: United Nations (UN). Published: 7/2020. This 30-page policy brief describes how cities can manage the COVID-19 pandemic and emerge as the hubs of energy, resilience, and innovation that make them such vibrant and appealing places for many to live. It also looks at how the pandemic has exposed deep inequalities in how people live in cities, and how cities serve their residents, with the most vulnerable suffering the most. (PDF)
06/16/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention (CDC). Published: 6/16/2020. This seven-page document describes two broad categories of digital contact tracing tools, how and where they can improve timeliness and efficiency in the contact tracing process, and defines their minimum and preferred features. Technology can support case investigation and contact tracing but cannot take the place of a trained public health workforce for interviewing, counseling, and providing support for those impacted by COVID-19. (PDF)
.png)
No hay comentarios:
Publicar un comentario